Unresectable Leiomyosarcoma

DrugDrug NameDrug Description
DB05109TrabectedinAn alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma).
DrugDrug NamePhaseStatusCount
DB11105Benzalkonium1Recruiting1
DB00997Doxorubicin1Completed1
DB00997Doxorubicin1Recruiting1
DB16252Nedisertib1Recruiting1
DB11730Ribociclib1Completed1
DB00759Tetracycline1Recruiting1
DB11945Avelumab1 / 2Terminated1
DB06589Pazopanib1 / 2Terminated1
DB11836Sapanisertib1 / 2Terminated1
DB05109Trabectedin1 / 2Terminated1
DB08875Cabozantinib2Active Not Recruiting1
DB06186Ipilimumab2Active Not Recruiting1
DB11793Niraparib2Withdrawn1
DB09035Nivolumab2Active Not Recruiting1
DB00853Temozolomide2Active Not Recruiting1
DB09074Olaparib2 / 3Recruiting1
DB06589Pazopanib2 / 3Recruiting1
DB00853Temozolomide2 / 3Recruiting1
DB05109Trabectedin2 / 3Recruiting1